Regenosca's TissueSpan technology utilizes a unique mesh that facilitates the body's natural cell attraction and organization for effective soft tissue regeneration. This approach eliminates the need for harvesting the patient's own tissue, reducing surgical pain and complications associated with traditional urethral stricture repair methods.
Funding
$1.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for soft tissue repair, such as in urethral stricture, often rely on synthetic grafts, cadaver tissues, or autologous tissue harvesting, which can lead to complications like rejection, limited tissue availability, donor-site morbidity, and scarring. Existing endoscopic treatments for urethral strictures have high failure rates.
Solution
Regenosca's TissueSpan technology offers a regenerative medicine solution for soft tissue repair, initially targeting urethral strictures. TissueSpan is a unique, naturally-absorbed mesh that facilitates the body's own cell attraction and organization to regenerate functional tissue. After diseased tissue removal, the TissueSpan implant acts as a temporary scaffold, enabling seamless healing and restoring patients to full health. This approach eliminates the need for harvesting the patient's own tissue, reducing surgical complexity and potential complications. Regenosca has demonstrated successful tissue regrowth in human trials using TissueSpan.
Target Audience
The primary target market includes urologists and reconstructive surgeons treating soft tissue defects, specifically urethral strictures, seeking a regenerative alternative to traditional grafting techniques.
Features
- Unique mesh design promoting natural cell infiltration and organization for tissue regeneration
- Temporary scaffold that is naturally absorbed by the body
- Eliminates the need for autologous tissue harvesting, reducing donor-site morbidity
- Compatible with endoscopic delivery techniques for minimally invasive procedures
- Demonstrated perfect tissue regrowth in human trials